Press release
CV Sciences, Inc. (OTC: CVSI) Investor Alert: Update in Lawsuit against . CV Sciences, Inc
A lawsuit is pending for certain investors in CV Sciences, Inc. (OTC: CVSI) shares.
Investors who purchased shares of CV Sciences, Inc. (OTC: CVSI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 24, 2018, a lawsuit was filed against CV Sciences, Inc. (OTC: CVSI) over alleged violations of Federal Securities Laws. The plaintiff claims that between June 19, 2017 and August 20, 2018, the Defendants failed to disclose that its Patent #15/426,617 received a non-final rejection from the USPTO on April 27, 2017, that a final rejection from the USPTO on December 14, 2017, and that as a result of the foregoing, Defendants' statements about CV Sciences' business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Those who purchased shares of CV Sciences, Inc. (OTC: CVSI) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CV Sciences, Inc. (OTC: CVSI) Investor Alert: Update in Lawsuit against . CV Sciences, Inc here
News-ID: 1957972 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Sciences
Navigating the Complexities of the Healthcare & Life Sciences Industry: Expertis …
The healthcare industry is rapidly evolving due to dynamic market forces, strict regulatory requirements, and changing consumer expectations. These factors create complex challenges that require a thoughtful approach for effective navigation. At The Life Sciences Research Company, our consulting services are specifically designed to tackle these intricate issues by utilizing a comprehensive understanding of the entire healthcare value chain.
Understanding the Players Across the Value Chain
Our expertise spans a wide range…
TNP-ATP Triethylammonium Salt Market | BOC Sciences, Cayman Chemical, Glentham L …
The global tnp-atp triethylammonium salt market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the tnp-atp triethylammonium salt market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Life Sciences and Material Sciences Sectors Drive Optical Microscope Market Grow …
[San Francisco, USA] - Trouve360Reports, a leading market research firm, has added the latest report on the global optical microscope market. The report offers a comprehensive analysis of the market, including market introduction, market overview, growth drivers, key players, and regional analysis. The report covers the forecast period of 2022-2028 and presents an in-depth analysis of the market's current status and future growth prospects.
The optical microscope is a widely used…
Global Cell Banking Outsourcing Market 2019 By SGS Life Sciences, Reliance Life …
The global Cell Banking Outsourcing market report offers a summary of a substantial number of statistics in the Cell Banking Outsourcing market. Data collected in the report highlights the current market trends. Also, it provides the users with the detailed statistics of the global Cell Banking Outsourcing market, helping them in planning for competitive business strategies.
The global report offers a complete guidance on the recent developments in the global Cell…
Global Nanostructured Carbon Composite Market 2018 - Emfutur Technologies, Appli …
Eminent Market Reports, recently published a detailed market research study focused on the “Nanostructured Carbon Composite Market” across the global, regional and country level. The report provides 360° analysis of “Nanostructured Carbon Composite Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Nanostructured…
Global Life Sciences BPO Market
The Global Life Sciences BPO Market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights.Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO).
Request Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/24
Increasing demand for low cost…
